Hello Heart Closes $70M Series D Funding

Hello Heart

Hello Heart, a Menlo Park, CA-based digital therapeutic company that focuses on heart health, raised $70m in Series D financing.

Stripes led the round.

The company intends to use the funds for growth in customer demand.

Led by Maayan Cohen, Co-Founder and CEO, Hello Heart is a digital therapeutics company that focuses exclusively on heart disease. Through a connected mobile app that uses AI, behavioral science, and personalized digital coaching to drive lifestyle changes, Hello Heart empowers people to embrace healthier behavior, which can reduce the risks of high blood pressure and heart disease. It also helps users catch readings that encourage them to talk to their doctor and catch potential risk in time.

Looking ahead, the company intends to deepen the use cases of their artificial intelligence (AI) engines to help manage heart health, which will include enhancing lifestyle digital coaching modules, and adding whole heart health functionality such as deeper medication tracking capabilities, cholesterol tracking and hyperlipidemia digital coaching.

Founded in 2013, Hello Heart is a member of the American Heart Association’s Innovators’ Network.